Soft Hyperbaric Chamber: What It Delivers, What It Doesn’t, and Who Should Buy One

A soft hyperbaric chamber operates at a maximum of 1.3 ATA with ambient air or concentrator-supplied oxygen delivered via face mask. It is a Class II medical device FDA-cleared for one indication: acute mountain sickness.¹ Every other marketed use — recovery, anti-aging, brain health, inflammation — is off-label, not supported by the FDA clearance, and not equivalent to clinical HBOT.

That said, soft chambers do have a real place in the market. They are affordable, portable, and accessible for home use. Understanding what they actually deliver — and what they cannot — helps buyers make honest decisions.

What a Soft Chamber Actually Delivers

At 1.3 ATA with ambient air (approximately 21% oxygen), the dissolved oxygen increase is roughly equivalent to breathing supplemental oxygen by mask at sea-level pressure, according to the South African Underwater and Hyperbaric Medical Association.² Blood oxygen saturation (SpO₂) increases from around 97% to 99%. A modest change since hemoglobin is already near-saturated at sea level.

With an oxygen concentrator providing 90 to 95% O₂ via mask inside the chamber, the effective dose increases meaningfully but still falls far short of clinical HBOT. At 1.3 ATA with concentrator O₂, arterial oxygen is approximately 230 mmHg. At clinical 2.4 ATA with 100% O₂, it reaches approximately 1,824 mmHg. An 8x difference.³

What the Clinical Evidence Says

Evidence for soft chamber pressures is limited and mixed. A 2011 study in 15 healthy volunteers found that sessions at 1.3 ATA reduced oxidative stress markers by 11% and improved fatigue scores. But had no control group and measured no clinical endpoints.⁴ A 2018 study in 10 participants found the highest oxygen saturation at 1.3 ATA with supplemental O₂. But again, no clinical endpoints and no disease population.⁵

For mTBI, the 2022 Harch systematic review found mixed results at 1.3 ATA with ambient air (one positive, one negative study) versus strong Level 1 evidence at 1.5 ATA with 100% oxygen (four positive RCTs).⁶ No studies have established benefit for wound healing, infection, or any UHMS-approved indication at soft chamber pressures.

Soft Chamber Brands and Pricing

Only three brands hold FDA 510(k) clearance for soft hyperbaric chambers in the US: OxyHealth, Summit to Sea, and Newtowne Hyperbarics. All are limited to 1.3 ATA. Every other brand sold through Amazon, eBay, or international distributors lacks FDA clearance.

What Are the Side Effects and Risks?

Soft chambers have a favorable safety profile at 1.3 ATA. A 2023 study of 175 patients at 1.45 ATA found a total adverse event rate of 7.1% per session, with all barotrauma events being subjective earache only. Zero cases of eardrum damage.⁷ Fire risk is very low because the chamber atmosphere is compressed air, not concentrated oxygen. The main risk is ear barotrauma from failure to equalize pressure, particularly in users with active congestion or sinus issues.

Who Soft Chambers Are Right For

Soft chambers suit home wellness users who want regular hyperbaric exposure, athletes using HBOT for recovery, and people who have already completed a clinical HBOT course and want to maintain a routine at home. They are not appropriate for anyone treating a UHMS-approved medical condition, which requires a hard shell hyperbaric chamber at 2.0+ ATA.

For a head-to-head comparison of the two types, see the hard shell vs soft shell hyperbaric chamber guide. For home installation options, see the home hyperbaric chamber buying guide.

FAQs

What is the maximum pressure of a soft hyperbaric chamber?
1.3 ATA for FDA-cleared models. Some non-FDA brands claim 1.5 ATA. No soft shell chamber reaches 2.0 ATA. The minimum pressure for clinical HBOT.

Do soft chambers deliver real HBOT?
They deliver compressed air at mild pressure. This differs meaningfully from clinical HBOT, which uses 100% oxygen at 2.0 to 3.0 ATA. The UHMS does not classify soft chamber sessions as HBOT.

Are soft chambers safe without medical supervision?
At 1.3 ATA with ambient air, the risks are low. The main risk is ear barotrauma if users don’t equalize properly. Users with active respiratory infections, pregnancy, or seizure history should consult a physician first.

References

References

1. FDA 510(k) clearance K051759. Newtowne Hyperbarics. accessdata.fda.gov
2. Burman F. Low-pressure fabric hyperbaric chambers. S Afr Med J. 2019;109(4). PMID: 31084683. https://doi.org/10.7196/SAMJ.2019.v109i4.13934
3. Ke G et al. Assessment of oxygen saturation levels during mild hyperbaric chamber treatment. J Clin Intensive Care Med. 2018. https://doi.org/10.15761/jcis.1000108
4. Kim S et al. Effect of mild-pressure hyperbaric therapy on fatigue and oxidative stress. Health. 2011;3(7). https://doi.org/10.4236/HEALTH.2011.37071
5. Ke G et al. 2018. (see ref 3)
6. Harch P. Systematic review and dosage analysis: HBOT in mTBI PCS. Front Neurol. 2022. PMID: 35370898. https://doi.org/10.3389/fneur.2022.815076
7. Monge G et al. Safety of HBOT and evaluation of associated clinical parameters. Int J Transl Med Res Public Health. 2023. https://doi.org/10.21106/ijtmrph.430

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website